CERO(Delisted)
CERo Therapeutics·NASDAQ
--
--(--)
CERO Filings
Filing Date
Form Description
Form Type
2026-03-12
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-12 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-11
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-11 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-11
Form 8-K - Current report
Key Events
2026-03-11 · Key Events
Form 8-K - Current report
2026-02-20
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-20 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-13
Form 8-K - Current report
Key Events
2026-02-13 · Key Events
Form 8-K - Current report
2026-02-04
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-04 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-04
Form 8-K - Current report
Key Events
2026-02-04 · Key Events
Form 8-K - Current report
2026-02-03
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-03 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2026-01-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
